125 related articles for article (PubMed ID: 38417041)
1. Differences in the levels of the appetite peptides ghrelin, peptide tyrosine tyrosine, and glucagon-like peptide-1 between obesity classes and lean controls.
Alyar G; Umudum FZ
Lab Med; 2024 Feb; ():. PubMed ID: 38417041
[TBL] [Abstract][Full Text] [Related]
2. Differences in gastrointestinal hormones and appetite ratings among obesity classes.
Aukan MI; Nymo S; Haagensli Ollestad K; Akersveen Boyesen G; DeBenedictis JN; Rehfeld JF; Coutinho S; Martins C
Appetite; 2022 Apr; 171():105940. PubMed ID: 35063622
[TBL] [Abstract][Full Text] [Related]
3. Changes in ghrelin, GLP-1, and PYY levels after diet and exercise in obese individuals.
Alyar G; Umudum FZ; Akbaş N
Rev Assoc Med Bras (1992); 2024; 70(1):e20230263. PubMed ID: 38511748
[TBL] [Abstract][Full Text] [Related]
4. Gut hormones as peripheral anti obesity targets.
Small CJ; Bloom SR
Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
[TBL] [Abstract][Full Text] [Related]
5. Effects of solid-phase extraction of plasma in measuring gut metabolic hormones in fasted and fed blood of lean and diet-induced obese rats.
Reidelberger R; Haver A; Anders K; Apenteng B; Lanio C
Physiol Rep; 2016 May; 4(10):. PubMed ID: 27207785
[TBL] [Abstract][Full Text] [Related]
6. Acute increases in serum colonic short-chain fatty acids elicited by inulin do not increase GLP-1 or PYY responses but may reduce ghrelin in lean and overweight humans.
Rahat-Rozenbloom S; Fernandes J; Cheng J; Wolever TMS
Eur J Clin Nutr; 2017 Aug; 71(8):953-958. PubMed ID: 27966574
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin PYY 3-36 serum changes in left ventricular hypertrophic, insulin-resistant, hypertensive obese patients.
Karcz-Socha I; Zwirska-Korczala K; Zembala M; Borgiel-Marek H; Karcz K
Obes Facts; 2011; 4(5):386-92. PubMed ID: 22166759
[TBL] [Abstract][Full Text] [Related]
8. Ghrelin suppresses cholecystokinin (CCK), peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) in the intestine, and attenuates the anorectic effects of CCK, PYY and GLP-1 in goldfish (Carassius auratus).
Blanco AM; Bertucci JI; Valenciano AI; Delgado MJ; Unniappan S
Horm Behav; 2017 Jul; 93():62-71. PubMed ID: 28506816
[TBL] [Abstract][Full Text] [Related]
9. The Association between Peptide Hormones with Obesity and Insulin Resistance Markers in Lean and Obese Individuals in the United Arab Emirates.
Ali Ahmad M; Karavetian M; Moubareck CA; Wazz G; Mahdy T; Venema K
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334929
[TBL] [Abstract][Full Text] [Related]
10. Appetite-related peptides in childhood and adolescence: role of ghrelin, PYY, and GLP-1.
Horner K; Lee S
Appl Physiol Nutr Metab; 2015 Nov; 40(11):1089-99. PubMed ID: 26466085
[TBL] [Abstract][Full Text] [Related]
11. Appetite-related gut peptides, ghrelin, PYY, and GLP-1 in obese women with and without binge eating disorder (BED).
Geliebter A; Hashim SA; Gluck ME
Physiol Behav; 2008 Aug; 94(5):696-9. PubMed ID: 18534636
[TBL] [Abstract][Full Text] [Related]
12. Diet and gastrointestinal bypass-induced weight loss: the roles of ghrelin and peptide YY.
Chandarana K; Gelegen C; Karra E; Choudhury AI; Drew ME; Fauveau V; Viollet B; Andreelli F; Withers DJ; Batterham RL
Diabetes; 2011 Mar; 60(3):810-8. PubMed ID: 21292870
[TBL] [Abstract][Full Text] [Related]
13. Oral ingestion of a hydrolyzed gelatin meal in subjects with normal weight and in obese patients: Postprandial effect on circulating gut peptides, glucose and insulin.
Rubio IG; Castro G; Zanini AC; Medeiros-Neto G
Eat Weight Disord; 2008 Mar; 13(1):48-53. PubMed ID: 18319637
[TBL] [Abstract][Full Text] [Related]
14. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
[TBL] [Abstract][Full Text] [Related]
15. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
16. [The changes of gastrointestinal hormones GLP-1, PYY and ghrelin in patients with newly diagnosed type 2 diabetes mellitus].
Cui T; Ren Y; Ma H; Liu SF; Zhang XX; Yu HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):774-8. PubMed ID: 24325110
[TBL] [Abstract][Full Text] [Related]
17. Mycoprotein reduces energy intake and postprandial insulin release without altering glucagon-like peptide-1 and peptide tyrosine-tyrosine concentrations in healthy overweight and obese adults: a randomised-controlled trial.
Bottin JH; Swann JR; Cropp E; Chambers ES; Ford HE; Ghatei MA; Frost GS
Br J Nutr; 2016 Jul; 116(2):360-74. PubMed ID: 27198187
[TBL] [Abstract][Full Text] [Related]
18. Comparison of postprandial profiles of ghrelin, active GLP-1, and total PYY to meals varying in fat and carbohydrate and their association with hunger and the phases of satiety.
Gibbons C; Caudwell P; Finlayson G; Webb DL; Hellström PM; Näslund E; Blundell JE
J Clin Endocrinol Metab; 2013 May; 98(5):E847-55. PubMed ID: 23509106
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of exercise on appetite, ad libitum energy intake and appetite-regulatory hormones in lean and overweight/obese men and women.
Douglas JA; King JA; Clayton DJ; Jackson AP; Sargeant JA; Thackray AE; Davies MJ; Stensel DJ
Int J Obes (Lond); 2017 Dec; 41(12):1737-1744. PubMed ID: 28769121
[TBL] [Abstract][Full Text] [Related]
20. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
